SGLT2 inhibitors: the statins of the 21st century
Author:
Affiliation:
1. TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Hale Building for Transformative Medicine, Suite 7022, 60 Fenwood Road, Boston, MA 02115, USA
2. Department of Medicine, Harvard Medical School, Boston, MA, USA
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine
Link
https://academic.oup.com/eurheartj/advance-article-pdf/doi/10.1093/eurheartj/ehab765/41099155/ehab765.pdf
Reference14 articles.
1. Über künstlichen Diabetes;Von Mering;Centralbl Med Wiss,1886
2. Phlorizin as a competitive inhibitor of the active transport of sugars by hamster small intestine in vitro;Alvarado;Biochim Biophys Acta,1962
3. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats;Rossetti;J Clin Invest,1987
4. Na+-glucose cotransporter inhibitors as antidiabetics. I. Synthesis and pharmacological properties of 4’-dehydroxyphlorizin derivatives based on a new concept;Tsujihara;Chem Pharm Bull,1996
5. T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats;Adachi;Metabolism,2000
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Trajetória das Gliflozinas: Da Casca da Macieira à Redução de Mortalidade Total na Insuficiência Cardíaca;ABC Heart Failure & Cardiomyopathy;2024-09-06
2. The Trajectory of Gliflozins: From Apple Tree Bark to Reduced Overall Mortality in Heart Failure;ABC Heart Fail Cardiomyop;2024-09
3. Mechanisms of heart failure and chronic kidney disease protection by SGLT2 inhibitors in nondiabetic conditions;American Journal of Physiology-Cell Physiology;2024-09-01
4. The Beneficial Effect of the SGLT2 Inhibitor Dapagliflozin in Alleviating Acute Myocardial Infarction-Induced Cardiomyocyte Injury by Increasing the Sirtuin Family SIRT1/SIRT3 and Cascade Signaling;International Journal of Molecular Sciences;2024-08-05
5. Diabetes and Heart Failure: A Literature Review, Reflection and Outlook;Biomedicines;2024-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3